Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.
- 1 May 1983
- Vol. 1 (5)
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit:
This publication has 0 references indexed in Scilit: